Arete Wealth Advisors LLC Acquires New Shares in Astera Labs, Inc. (NASDAQ:ALAB)

Arete Wealth Advisors LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 7,950 shares of the company’s stock, valued at approximately $1,053,000.

Other institutional investors also recently bought and sold shares of the company. Whittier Trust Co. of Nevada Inc. bought a new stake in shares of Astera Labs during the 4th quarter worth about $25,000. Steward Partners Investment Advisory LLC boosted its position in Astera Labs by 99.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC bought a new stake in Astera Labs during the fourth quarter worth approximately $28,000. Geneos Wealth Management Inc. acquired a new position in Astera Labs during the fourth quarter valued at approximately $36,000. Finally, Global Retirement Partners LLC raised its position in shares of Astera Labs by 3,155.6% in the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock valued at $39,000 after purchasing an additional 284 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Down 4.9 %

Shares of ALAB opened at $52.94 on Friday. The stock has a 50 day simple moving average of $78.49 and a 200-day simple moving average of $90.43. The stock has a market cap of $8.58 billion and a PE ratio of -30.60. Astera Labs, Inc. has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. On average, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on ALAB. Needham & Company LLC reiterated a “buy” rating and issued a $140.00 target price on shares of Astera Labs in a research note on Tuesday, February 11th. Craig Hallum raised their price target on Astera Labs from $105.00 to $125.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Stifel Nicolaus boosted their price objective on Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Raymond James started coverage on Astera Labs in a report on Friday, March 14th. They issued an “outperform” rating and a $82.00 target price on the stock. Finally, Barclays upped their target price on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research note on Friday, January 17th. One analyst has rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Astera Labs currently has an average rating of “Buy” and a consensus price target of $112.77.

Insiders Place Their Bets

In related news, Director Michael E. Hurlston sold 2,500 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $92.08, for a total transaction of $230,200.00. Following the sale, the director now directly owns 91,794 shares in the company, valued at $8,452,391.52. This represents a 2.65 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jitendra Mohan sold 350,680 shares of Astera Labs stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $89.51, for a total value of $31,389,366.80. Following the completion of the transaction, the chief executive officer now owns 2,353,655 shares of the company’s stock, valued at approximately $210,675,659.05. The trade was a 12.97 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 633,990 shares of company stock valued at $54,235,012.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.